Literature DB >> 3257978

Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity.

N Seki1, Y Sudo, T Yoshioka, S Sugihara, T Fujitsu, S Sakuma, T Ogawa, T Hamaoka, H Senoh, H Fujiwara.   

Abstract

Immunization of DBA/1 mice with type II collagen resulted in typical and progressive arthritis, which is associated with the production of high titer of anti-collagen antibody and the induction of cell-mediated immunity as exemplified by delayed type hypersensitivity response as well as lymphokine production. In contrast, administration of heat-denatured collagen into DBA/1 mice failed to induce the arthritis. These mice produced only marginal antibody, whereas they developed comparable cell-mediated immunity to that induced by immunization with native collagen, and therefore the inoculation of heat-denatured collagen provided the regimen capable of inducing preferentially cell-mediated immunity without the generation of high level of antibody. Inasmuch as administration of antibody induced only marginal and transient joint swelling not associated with typical histologic lesion, the synergistic effect of humoral and cell-mediated immunities was investigated using antibody preparation and the regimen to induce selectively cell-mediated immunity. The results demonstrate that administration of antibody into DBA/1 mice pre-sensitized with heat-denatured collagen resulted in potent and progressive arthritis. Such synergy was further confirmed by the induction of arthritis in T cell-depleted DBA/1 mice that had been adoptively transferred with antibody and lymphoid cells from heat-denatured collagen-sensitized mice. Moreover, it was revealed that the nature of cells capable of transferring cell-mediated immunity was of Thy-1+ and L3T4+ Lyt-2-. These results indicate that anti-collagen antibody and L3T4+ T cell-mediated cellular immunity are crucially required for the perpetuated development of type II collagen-induced arthritis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257978

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  78 in total

1.  Antigen presentation of Type II collagen in rats.

Authors:  B Catchpole; N A Staines; A S Hamblin
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

2.  Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking.

Authors:  R A Carter; I K Campbell; K L O'Donnel; I P Wicks
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

3.  Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis.

Authors:  Y Morita; J Yang; R Gupta; K Shimizu; E A Shelden; J Endres; J J Mulé; K T McDonagh; D A Fox
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

4.  Restricted heterogeneity in T-cell antigen receptor V beta gene usage in the lymph nodes and arthritic joints of mice.

Authors:  T M Haqqi; G D Anderson; S Banerjee; C S David
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

5.  Down-regulation of collagen arthritis after in vivo treatment with a syngeneic monoclonal anti-idiotypic antibody to a cross-reactive idiotope on collagen II auto-antibodies.

Authors:  C Nordling; R Holmdahl; L Klareskog
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

6.  JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis.

Authors:  Katja Denninger; Susanne Rasmussen; Jeppe Madura Larsen; Catrine Orskov; Steen Seier Poulsen; Poul Sørensen; Jan Pravsgaard Christensen; Harald Illges; Niels Odum; Tord Labuda
Journal:  Am J Pathol       Date:  2011-08-11       Impact factor: 4.307

7.  The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis.

Authors:  Mae-Xhum Wong; John D Hayball; P Mark Hogarth; Denise E Jackson
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

8.  A study on type II collagen-induced arthritis in allogeneic bone marrow chimaeras.

Authors:  M Fujita; M Mishima; K Iwabuchi; C Katsume; T Gotohda; K Ogasawara; Y Mizuno; R A Good; K Onoé
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

9.  The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen.

Authors:  C Porporatto; M M Canali; I D Bianco; S G Correa
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

10.  Deficiency of β-arrestin1 ameliorates collagen-induced arthritis with impaired TH17 cell differentiation.

Authors:  Juan Li; Bin Wei; Ao Guo; Chang Liu; Shichao Huang; Fang Du; Wei Fan; Chunde Bao; Gang Pei
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.